These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 23152849)

  • 1. Early endogenous activation of CB1 and CB2 receptors after spinal cord injury is a protective response involved in spontaneous recovery.
    Arevalo-Martin A; Garcia-Ovejero D; Sierra-Palomares Y; Paniagua-Torija B; Gonzalez-Gil I; Ortega-Gutierrez S; Molina-Holgado E
    PLoS One; 2012; 7(11):e49057. PubMed ID: 23152849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The endocannabinoid 2-arachidonoylglycerol reduces lesion expansion and white matter damage after spinal cord injury.
    Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E
    Neurobiol Dis; 2010 May; 38(2):304-12. PubMed ID: 20156559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Remote Ischemia Preconditioning Attenuates Blood-Spinal Cord Barrier Breakdown in Rats Undergoing Spinal Cord Ischemia Reperfusion Injury: Associated with Activation and Upregulation of CB1 and CB2 Receptors.
    Jing N; Fang B; Wang ZL; Ma H
    Cell Physiol Biochem; 2017; 43(6):2516-2524. PubMed ID: 29130941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synthetic cannabinoid WIN55212-2 ameliorates traumatic spinal cord injury via inhibition of GAPDH/Siah1 in a CB2-receptor dependent manner.
    Su BX; Chen X; Huo J; Guo SY; Ma R; Liu YW
    Brain Res; 2017 Sep; 1671():85-92. PubMed ID: 28716633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro.
    Veeraraghavan P; Dekanic A; Nistri A
    Neuroscience; 2016 Oct; 333():214-28. PubMed ID: 27450568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating the Effects of Exogenous and Endogenous 2-Arachidonoylglycerol on Retinal CB1 Cannabinoid Receptors and Reactive Microglia in Naive and Diseased Retina.
    Papadogkonaki S; Spyridakos D; Lapokonstantaki E; Chaniotakis N; Makriyannis A; Malamas MS; Thermos K
    Int J Mol Sci; 2023 Oct; 24(21):. PubMed ID: 37958673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opposing roles of CB
    Gobira PH; Oliveira AC; Gomes JS; da Silveira VT; Asth L; Bastos JR; Batista EM; Issy AC; Okine BN; de Oliveira AC; Ribeiro FM; Del Bel EA; Aguiar DC; Finn DP; Moreira FA
    Br J Pharmacol; 2019 May; 176(10):1541-1551. PubMed ID: 30101419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cannabinoid CB
    Weresa J; Pędzińska-Betiuk A; Kossakowski R; Malinowska B
    Pharmacol Rep; 2019 Feb; 71(1):82-89. PubMed ID: 30500553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Receptor-heteromer mediated regulation of endocannabinoid signaling in activated microglia. Role of CB
    Navarro G; Borroto-Escuela D; Angelats E; Etayo Í; Reyes-Resina I; Pulido-Salgado M; Rodríguez-Pérez AI; Canela EI; Saura J; Lanciego JL; Labandeira-García JL; Saura CA; Fuxe K; Franco R
    Brain Behav Immun; 2018 Jan; 67():139-151. PubMed ID: 28843453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposite effects of cannabinoid CB
    Li L; Dong X; Tu C; Li X; Peng Z; Zhou Y; Zhang D; Jiang J; Burke A; Zhao Z; Jin L; Jiang Y
    Br J Pharmacol; 2019 Apr; 176(7):890-905. PubMed ID: 30707759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial-dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation.
    Latini L; Bisicchia E; Sasso V; Chiurchiù V; Cavallucci V; Molinari M; Maccarrone M; Viscomi MT
    Cell Death Dis; 2014 Sep; 5(9):e1404. PubMed ID: 25188514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging.
    Pascual AC; Gaveglio VL; Giusto NM; Pasquaré SJ
    Exp Gerontol; 2014 Jul; 55():134-42. PubMed ID: 24768821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pharmacology of cannabinoid receptors and their ligands: an overview.
    Pertwee RG
    Int J Obes (Lond); 2006 Apr; 30 Suppl 1():S13-8. PubMed ID: 16570099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CB1 and CB2 cannabinoid receptor antagonists prevent minocycline-induced neuroprotection following traumatic brain injury in mice.
    Lopez-Rodriguez AB; Siopi E; Finn DP; Marchand-Leroux C; Garcia-Segura LM; Jafarian-Tehrani M; Viveros MP
    Cereb Cortex; 2015 Jan; 25(1):35-45. PubMed ID: 23960212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis.
    Wen J; Ribeiro R; Tanaka M; Zhang Y
    Neuropharmacology; 2015 Dec; 99():196-209. PubMed ID: 26189763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hypothermic response to bacterial lipopolysaccharide critically depends on brain CB1, but not CB2 or TRPV1, receptors.
    Steiner AA; Molchanova AY; Dogan MD; Patel S; Pétervári E; Balaskó M; Wanner SP; Eales J; Oliveira DL; Gavva NR; Almeida MC; Székely M; Romanovsky AA
    J Physiol; 2011 May; 589(Pt 9):2415-31. PubMed ID: 21486787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular and cellular changes in the lumbar spinal cord following thoracic injury: regulation by treadmill locomotor training.
    Shin HY; Kim H; Kwon MJ; Hwang DH; Lee K; Kim BG
    PLoS One; 2014; 9(2):e88215. PubMed ID: 24520355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of endogenous cannabinoid anandamide on excitation-contraction coupling in rat ventricular myocytes.
    Al Kury LT; Voitychuk OI; Ali RM; Galadari S; Yang KH; Howarth FC; Shuba YM; Oz M
    Cell Calcium; 2014 Feb; 55(2):104-18. PubMed ID: 24472666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for a role of endocannabinoids, astrocytes and p38 phosphorylation in the resolution of postoperative pain.
    Alkaitis MS; Solorzano C; Landry RP; Piomelli D; DeLeo JA; Romero-Sandoval EA
    PLoS One; 2010 May; 5(5):e10891. PubMed ID: 20531936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral deficiency and antiallodynic effects of 2-arachidonoyl glycerol in a mouse model of paclitaxel-induced neuropathic pain.
    Thomas A; Okine BN; Finn DP; Masocha W
    Biomed Pharmacother; 2020 Sep; 129():110456. PubMed ID: 32603895
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.